[The use of Vasaprostan in patients with systemic lupus erythematosus and the antiphospholipid syndrome].
Reshetniak
T M
TM
Alekberova
Z S
ZS
Nasonova
V A
VA
D000328:Adult; D000527:Alprostadil / Q000627:therapeutic use*; D016736:Antiphospholipid Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D002908:Chronic Disease; D018450:Disease Progression; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D014665:Vasodilator Agents / Q000627:therapeutic use*
D014665:Vasodilator Agents; D000527:Alprostadil
Primenenie vazaprostana u bol'nykh sistemnoĭ krasnoĭ volchankoĭ s antifosfolipidnym sindromom.